NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
24/04/2026
Voltar para busca
Dado oficial do USPTO
CC CELULARITY
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
50
Atualização mais recente
25/04/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
42
Data de depósito
27/06/2018
Data de registro
07/01/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/04/2026
Última transação
25/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
702
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
16/05/2018
Primeiro uso no comércio
16/05/2018
Código do desenho
5
Tipo de titular
11
Localização do titular
SINGAPORE, SG
Examinador
FALK, JONATHAN ROBERT
Localização atual
Historical data usage
Descrição da marca
The mark consists of a purple tilted "C" next to a green backwards tilted "C" forming an infinity symbol above the word "CELULARITY" in purple.
Titulares e representantes
Titulares
CELENIV PTE. LTD.
CELULARITY INC.
Celularity, Inc.
Celularity, Inc.
Representantes
Camille M. Miller COZEN O'CONNOR
Classificação técnica
Classes Nice
Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Researchdevelopment and testing services for others in the fields of genomicsbiotechnology and pharmaceuticals; stem cell research services; researchdevelopment and testing services in the fields of genomicsbiotechnology and pharmaceuticalscollectiontestingprocessingpreservationstorage and retrieval of cells and biological tissuebloodstem cellsumbilical cordsumbilical cord bloodplacental tissue; collectiontestingprocessingpreservationstorage and retrieval of bioengineered cellshuman allograft tissue made from human umbilical cords and human placentashuman amniotic membrane and human chorionic membranehuman collagen and extracellular matrix compositions; providing written materials and a website featuring information in the field of medical research relating to banking stem cells and cord blood banking; biosourcing of clinically accessibleimmune-tolerant human stem and progenitor and other postpartum placenta-derived cell populations and tissues for medical research; medical research to find methods to restore the structure and function of damaged or diseased tissues and organsincluding wound carereconstructive medicinewhole organ and tissue regeneration and renewal; medical research regarding emergent cell therapies; medical research regarding allogeneic immunotherapy; providing on-line informationnews and commentary in the field of medical research relating to the foregoing
Publicações
Histórico de despachos e eventos da marca no USPTO.
50 publicações encontradas
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
24/04/2026
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
24/04/2026
PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
24/04/2026
PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
30/03/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
30/03/2026
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/01/2026
E815
TEAS SECTION 8 & 15 RECEIVED
06/01/2026
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/01/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
12/01/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/10/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/10/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/10/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/10/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/10/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
07/01/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/12/2019
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/12/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/11/2019
DPCC
DIVISIONAL PROCESSING COMPLETE
08/11/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/11/2019
IUAF
USE AMENDMENT FILED
29/10/2019
DRRR
DIVISIONAL REQUEST RECEIVED
29/10/2019
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
29/10/2019
EISU
TEAS STATEMENT OF USE RECEIVED
29/10/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
30/05/2019
EX1G
SOU EXTENSION 1 GRANTED
28/05/2019
EXT1
SOU EXTENSION 1 FILED
28/05/2019
EEXT
SOU TEAS EXTENSION RECEIVED
28/05/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
25/12/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
30/10/2018
PUBO
PUBLISHED FOR OPPOSITION
30/10/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/10/2018
ALIE
ASSIGNED TO LIE
23/09/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/09/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/09/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/09/2018
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
04/09/2018
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
30/08/2018
GNFR
FINAL REFUSAL E-MAILED
30/08/2018
CNFR
FINAL REFUSAL WRITTEN
30/08/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/08/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/08/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/08/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
24/07/2018
GNRT
NON-FINAL ACTION E-MAILED
24/07/2018
CNRT
NON-FINAL ACTION WRITTEN
24/07/2018
DOCK
ASSIGNED TO EXAMINER
23/07/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/07/2018
NWAP
NEW APPLICATION ENTERED
30/06/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CC CELULARITY ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.